Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Teva Pharmaceutical Industries ADR (TEVA)

Teva Pharmaceutical Industries ADR (TEVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Teva Pharmaceutical Industries ADR 124 DVORA HANEVI'a STREET TEL AVIV L3 6944020 ISR

www.tevapharm.com Employees: 36,830 P: 972-3914-8213

Sector:

Medical

Description:

Teva Pharmaceutical Industries Limited is a global pharmaceutical company that develops, manufactures, and markets both branded and generic drugs, as well as active pharmaceutical ingredients in North America, Europe, Latin America, India, and Israel. Teva's generic product portfolio includes tablets, capsules, liquids, ointments, creams, liquids, injectables, and inhalants. The company's branded products include Copaxone, Austedo, respiratory products like ProAir and Qvar and Ajovy. Teva operates through three segments, North America, Europe and International Markets, each of which includes generics, specialty and over-the-counter products. Teva acquired Allergan's generics business Actavis Generics. The company also acquired Allergan's Anda Inc. Teva acquired Auspex Pharmaceuticals and Barr. Teva has strengthened its position in Europe through its acquisition of Germany's second largest generics producer, ratiopharm.

Key Statistics

Overview:

Market Capitalization, $K 37,241,792
Enterprise Value, $K 52,064,792
Shares Outstanding, K 1,146,960
Annual Sales, $ 16,544 M
Annual Net Income, $ -1,639 M
Last Quarter Sales, $ 4,480 M
Last Quarter Net Income, $ 433,000 K
EBIT, $ 2,416 M
EBITDA, $ 3,475 M
60-Month Beta 0.66
% of Insider Shareholders 0.49%
% of Institutional Shareholders 54.05%
Float, K 1,141,340
% Float 99.51%
Short Interest 44,936
Short Float 3.92%
Short Volume Ratio 0.44

Growth:

1-Year Return 56.08%
3-Year Return 211.91%
5-Year Return 158.73%
5-Year Revenue Growth -2.03%
5-Year Earnings Growth 3.90%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.78 on 11/05/25
Next Earnings Date 01/28/26 [BMO]
Earnings Per Share ttm 2.58
EPS Growth vs. Prev Qtr 17.19%
EPS Growth vs. Prev Year 11.94%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Most Recent Dividend 0.072 on 11/27/17
Next Ex-Dividends Date 11/27/17
Dividend Payable Date 03/03/15
Dividend Payout Ratio 0.00%
Most Recent Split 2-1 on 07/01/04

TEVA Ratios

Ratio
Price/Earnings ttm 12.71
Price/Earnings forward 12.47
Price/Earnings to Growth 1.88
Return-on-Equity % 46.13%
Return-on-Assets % 7.53%
Profit Margin % -9.91%
Debt/Equity 2.31
Price/Sales 2.23
Price/Cash Flow 9.75
Price/Book 5.18
Book Value/Share 6.32
Interest Coverage -0.78
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar